HARVARD BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
HARVARD BIOSCIENCE, INC. (HBIO) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period of 1.47 million shares for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod · last filed 2019-11-08
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-09-30 was 872.91K shares, a 2633.64% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-06-30 was 216.15K shares, a 50.37% decline year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2019-03-31 was 383.83K shares, a 172.68% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for the quarter ending 2018-12-31 was 30.94K shares, a 572.54% increase year-over-year.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2018 was 639.13K shares, a 50.77% decline from fiscal 2017.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2017 was 1.30M shares, a 18.55% increase from fiscal 2016.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2016 was 1.10M shares, a 330.02% increase from fiscal 2015.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, grants in period for fiscal 2015 was 254.69K shares, a 118.80% increase from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period 12 month |
|---|---|---|---|---|
| 2019-09-30 | 872.91K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | 1.09M shares derived: sum of 2 quarters · filed 2019-11-08 | 1.47M shares 10-Q · filed 2019-11-08 | 1.50M shares derived: sum of 4 quarters · filed 2019-11-08 |
| 2019-06-30 | 216.15K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 599.98K shares 10-Q · filed 2019-08-08 | 630.91K shares derived: sum of 3 quarters · filed 2019-08-08 | 662.85K shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | 383.83K shares 10-Q · filed 2019-05-08 | 414.76K shares derived: sum of 2 quarters · filed 2019-05-08 | 446.70K shares derived: sum of 3 quarters · filed 2019-05-08 | 882.19K shares derived: sum of 4 quarters · filed 2019-05-08 |
| 2018-12-31 | 30.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 62.87K shares derived: sum of 2 quarters · filed 2019-03-18 | 498.36K shares derived: sum of 3 quarters · filed 2019-03-18 | 639.13K shares 10-K · filed 2019-03-18 |
| 2018-09-30 | 31.93K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 467.43K shares derived: sum of 2 quarters · filed 2018-11-01 | 608.19K shares 10-Q · filed 2018-11-01 | 612.79K shares derived: sum of 4 quarters · filed 2019-03-18 |
| 2018-06-30 | 435.49K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 576.26K shares 10-Q · filed 2018-08-02 | 580.86K shares derived: sum of 3 quarters · filed 2019-03-18 | 588.31K shares derived: sum of 4 quarters · filed 2019-03-18 |
| 2018-03-31 | 140.76K shares 10-Q · filed 2018-05-10 | 145.36K shares derived: sum of 2 quarters · filed 2019-03-18 | 152.81K shares derived: sum of 3 quarters · filed 2019-03-18 | 993.44K shares derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-12-31 | 4.60K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | 12.05K shares derived: sum of 2 quarters · filed 2019-03-18 | 852.68K shares derived: sum of 3 quarters · filed 2019-03-18 | 1.30M shares 10-K · filed 2019-03-18 |
| 2017-09-30 | 7.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | 848.08K shares derived: sum of 2 quarters · filed 2017-11-02 | 1.29M shares 10-Q · filed 2017-11-02 | 1.29M shares derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-06-30 | 840.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 1.29M shares 10-Q · filed 2017-08-03 | 1.29M shares derived: sum of 3 quarters · filed 2018-03-16 | 1.44M shares derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-03-31 | 445.69K shares 10-Q · filed 2017-05-08 | 445.69K shares derived: sum of 2 quarters · filed 2018-03-16 | 599.69K shares derived: sum of 3 quarters · filed 2018-03-16 | 1.43M shares derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 154.00K shares derived: sum of 2 quarters · filed 2018-03-16 | 984.79K shares derived: sum of 3 quarters · filed 2018-03-16 | 1.10M shares 10-K · filed 2018-03-16 |
| 2016-09-30 | 154.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | 984.79K shares derived: sum of 2 quarters · filed 2016-11-03 | 1.10M shares 10-Q · filed 2016-11-03 | 1.10M shares derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-06-30 | 830.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | 941.19K shares 10-Q · filed 2016-08-04 | 941.19K shares derived: sum of 3 quarters · filed 2018-03-16 | 941.19K shares derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-03-31 | 110.40K shares 10-Q · filed 2016-05-16 | 110.40K shares derived: sum of 2 quarters · filed 2018-03-16 | 110.40K shares derived: sum of 3 quarters · filed 2018-03-16 | |
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2018-03-16 | 254.69K shares 10-K · filed 2018-03-16 | |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | 254.69K shares 10-Q · filed 2015-11-05 | ||
| 2015-06-30 | 254.69K shares 10-Q · filed 2015-08-06 | |||
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-17 | 0.00 shares derived: sum of 2 quarters · filed 2017-03-17 | 116.40K shares 10-K · filed 2017-03-17 | |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | 116.40K shares 10-Q · filed 2014-11-06 | ||
| 2014-06-30 | 116.40K shares 10-Q · filed 2014-08-07 | |||
| 2013-12-31 | 135.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | 135.65K shares derived: sum of 2 quarters · filed 2016-04-29 | 259.93K shares derived: sum of 3 quarters · filed 2016-04-29 | 259.93K shares 10-K · filed 2016-04-29 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | 124.28K shares derived: sum of 2 quarters · filed 2013-11-08 | 124.28K shares 10-Q · filed 2013-11-08 | 124.28K shares derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | 124.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | 124.28K shares 10-Q · filed 2013-08-09 | 124.28K shares derived: sum of 3 quarters · filed 2015-03-12 | 124.28K shares derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-10 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-12 | 0.00 shares derived: sum of 3 quarters · filed 2015-03-12 | |
| 2012-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | 0.00 shares derived: sum of 2 quarters · filed 2015-03-12 | 349.30K shares 10-K · filed 2015-03-12 | |
| 2012-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | 349.30K shares 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | 349.30K shares 10-Q · filed 2012-08-09 | |||
| 2011-12-31 | 188.75K shares 10-K · filed 2014-03-14 | |||
| 2010-12-31 | 467.60K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |